Evolving 340B: Moving from Discounts to Rebates

Join Jeremy Docken, Founder and CEO of Kalderos, and Adam J. Fein, Ph.D., CEO of Drug Channels Institute, for a live video webinar to learn about an innovative solution for the 340B Drug Pricing Program. They will discuss how to improve compliance and create transparency by converting 340B discounts to rebates. This live, interactive presentation and discussion will feature:

· An overview of compliance and operational challenges facing the 340B Program

· Why 340B rebates can eliminate duplicate discounts

· How covered entities, manufacturers, state Medicaid programs, and other stakeholders will benefit from 340B rebates

Jeremy and Adam will also take questions from the audience. Registration is free and open to all. The webinar is scheduled for one hour.